
Desert Peak Minerals, an owner of mineral rights and royalties, announced on Wednesday, January 12, it would merge with rival Falcon Minerals to go public in a deal valuing the combined company at US$1.9 billion, reported Reuters.
The merger comes at a time when oil prices have climbed to multi-year highs, spurred by a rebound in fuel demand and supply disruptions. Brent crude was trading at around US$84 a barrel on Wednesday.
Desert Peak, set up by energy-focused hedge fund Kimmeridge Energy Partners, buys and manages oil and gas minerals and royalty interests in the Permian basin of Texas and New Mexico.
Holders of mineral rights, like Desert Peak and Falcon, generally lease the properties to oil and gas producers for drilling and daily activities, in turn receiving a share of the income, or royalty, generated from the sale of the resources.
Desert Peak and Falcon will together own more than 139,000 net royalty acres in the Permian basin with expected production of around 13,500 to 14,500 barrels of oil equivalent per day in the first half of this year.
Desert Peak, which had filed for an initial public offering last year but reportedly postponed the plan in November, will own 73% of the combined company and Falcon will own the rest.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas